Increased TNF-α release is clearly correlated with dysregulated ADAM17 activity in autoimmune conditions [17,20,23], such as rheumatoid arthritis (RA), SS, systemic lupus erythematosus (SLE), psoriasis, and Crohn’s disease (CD) [17,24]. Here, ADAM17 is linked to rheumatoid arthritis.